Syntex' Cytovene (ganciclovir)
Executive Summary
Syntex' Cytovene (ganciclovir): Application requesting approval to export the antiviral to the U.K. has been submitted to FDA, according to Jan. 25 Federal Register notice. In October 1987, FDA's Anti-Infective Drug Products Advisory Committee voted not to recommend ganciclovir for treatment of cytomegalovirus retinitis in AIDS patients.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.